The Minister of Health, Alexandru Rafila, announced on Tuesday, in Constanta, that they are trying to find solutions for the outpatient administration of the innovative anti-COVID drug Favipiravir, an antiviral that can shorten by two to three days the duration of the disease, but which does not in any way influence the complicated forms and death".
The minister of health noted that in the case of Arbidol, an antiviral drug that is highly publicized, "there is no global study to show that it in any way influences the infection with the new coronavirus."
According to the minister of health, the number of cases of COVID-19 infection recorded in the middle of this week is 1.5 times higher than that recorded last week, given that our country has one of the fastest growth in Europe in terms of the reproduction rate of the infection, Agerpres informs.